Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2365753Generated: October 30, 2026

Sodium Carbonate → 3-(4-aminophenyl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine

https://huagongshe.com/reaction/2365753

Reaction equation

Participants

RoleNameHCIDCharge
ReactantSodium CarbonateHCID 10340—
Reactant4-Nitrophenylboronic acidHCID 2773552—
Reactant3-iodo-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amineHCID 24905337—
Reactant1-isopropyl-3-(4-nitrophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amineHCID 58506748—
CatalystZincHCID 23994—
CatalystHCID 178527696HCID 178527696—
SolventAcetic AcidHCID 176—
SolventEthanolHCID 702—
SolventTetrahydrofuranHCID 8028—
Product3-(4-aminophenyl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amineHCID 58506796—

Reaction Steps

With reference to Scheme 5, 4-nitrophenyl boronic acid (100 mg, 0.330 mmol; Sigma-Aldrich), was coupled to 3-iodo-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (140 mg, 0.8248 mmol; Apsel et al., 2008) via the Suzuki reaction in 6 mL 1,2 methoxy ethane, 1 mL of saturated sodium carbonate, 1.65 mL EtOH, and 200 mg of polymer-bound tetrakis Palladium. The reaction was stirred under argon for 12 hours at room temperature, filtered through Whatman paper to remove Palladium, mixed with brine, extracted in chloroform and the product was subsequently purified on silica in EtOAc and concentrated in vacuo. The purified solid 1-isopropyl-3-(4-nitrophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (ESI-MS m/z [M+H]+ found 299.1, calculated 299.1; 100 mg, 0.336 mmol) was combined with Zinc dust, 5 mL THF, 0.4 mL HOAc for 12 hours at room temperature under Argon. Then the reaction mixture was filtered through Celite®, extracted with EtOAc and concentrated in vacuo to yield 3-(4-aminophenyl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (ESI-MS m/z [M+H]+ found 269.1, calculated 269.1). To this reduced product, molar equivalents of 3-(trifluoromethyl)phenyl isocyanate (Sigma-Aldrich) were added dropwise in ice-cold CH2Cl2. The reaction proceeded until completion as judged by TLC, was concentrated in vacuo, resuspended in 50:50 H20-CH3CN, and purified on a C18 column in CH3CN/H20/0.1% TFA (1-100% gradient) to yield Cmpd 5 1-(4-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea (ESI-MS m/z [M+H]+ found 455.2, calculated 455.2; 1H NMR (400 MHz, DMSO): δ 9.48 (s, 1H), 9.42 (s, 1H), 8.39 (s, 1H), 8.07 (s, 1H), 7.70 (d, J=8 Hz, 2H), 7.60 (d, J=8 Hz, 2H), 7.60-7.64 (m, 1H), 7.53 (t, J=8 Hz, 1H), 7.33 (d, J=8 Hz, 1H), 5.10 (septet, J=6.8 Hz, 1H), 1.51 (d, J=6 Hz, 6H), 3.10 (q, J=4 Hz, 1.5H, trace triethylamine), 1.18 (t, J=8 Hz, 2H, trace triethylamine). 13C NMR (400 MHz, DMSO): δ 9.08 (trace triethylamine), 22.23, 46.20 (trace triethylamine), 49.17, 97.40, 115.45, 116.0 (d), 119.20, 122.34, 124.70 (q), 126.19, 129.35, 130.00 (q), 130.40, 140.85, 141.09, 145.20, 151.70, 152.35, 153.00, 155.72, 159.41 (q)).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08697709B2
Source datasetuspto-grants-2014_04
ORD IDord-99d2e163b9984a2ea64dbd5e8e3e6749
Source noteuspto-grants-2014_04